In another double-blinded study, oral L-arginine supplementation improved both peripheral and hepatic insulin sensitivity in T2DM patients, likely via normalization of the NO/cyclic-guanosine-3′5′-cyclic monophosphate (cGMP) pathway [115]. Here, INS is linked to type 2 diabetes mellitus.